Must have hemoglobin (Hgb) ? . g/dL within  days prior to randomization. Must not have required transfusion of red blood cells within  week of baseline Hgb assessment.
Patients with Hgb > . g/dl (transfusion allowed)
Additional Laboratory Requirements ANC ?. x /L Hgb ? g/dL(transfusion permitted) Platelet count ?. x /L
Obtained within  days prior to registration: Hemoglobin (Hgb) >=  g/dL (without erythrocyte stimulating agent or transfusion within  days of screening)
Hgb > . (transfusion allowed)
Hemoglobin (HgB) >  g/dL. Must not have required transfusion of red blood cells within  week of baseline Hgb assessment.
Hemoglobin (Hgb) >=  g/dL (with/without transfusion)
Hgb > . (transfusion allowed)
Hemoglobin (Hgb) >=  g/dL (acceptable to reach via transfusion) obtained within  days prior to initiating study treatment.
Hemoglobin (Hgb) <  mg/dl, per PI discretion if thought to be related to underlying myeloma
Hemoglobin (Hgb) >=  g/dL (more than  hours post-completion of blood transfusion)
Hemoglobin (Hgb) >=  g/dL (in absence of blood transfusion).
Within  weeks of day : Hemoglobin (HgB) >= . gr/dL independent of transfusion
Hemoglobin (Hgb) ?  g/dL obtained ?  days prior to randomization; patient may receive transfusion as needed
Hemoglobin (Hgb) >=  g/dL or >= . mmol/L without (w/o) transfusion within  days of assessment.
Hemoglobin (Hgb) >=  g/dL; (last transfusion cannot be within  days of trial initiation)
Hemoglobin (Hgb) >=  g/dL (use of transfusion to reach this threshold prior to study initiation is acceptable)
EXCLUSION CRITERIA FOR PATIENTS WITH NSCLC OR TNBC (COHORT B): Hemoglobin (Hgb) <  mg/dl (transfusion permitted to achieve this)
EXCLUSION CRITERIA FOR TNBC: Hgb <  mg/dl (transfusion permitted to achieve this)
PRIOR TO CELL PROCUREMENT: Hemoglobin (Hgb) ? . g/dL (transfusion independent for  weeks prior to enrollment)
Within  days prior to study entry: Hemoglobin (Hgb) > . g/dL (with or without transfusion)
TREATMENT: Hgb > . (transfusion allowed)
Hemoglobin (HgB) > . g/dL; NOTE: subjects may not have had a transfusion within  days of registration
Within  days of study drug(s) initiation: Hemoglobin (Hgb) >=  g/dL with no blood transfusion in the past  days.
Hemoglobin (Hgb) >=  g/dl (transfusion acceptable)
HGB ? g/dl and not transfusion dependent
Hemoglobin (HgB) >  g/dL (acceptable to reach this by transfusion)
Within  days of study start: Hemoglobin (Hgb) >=  g/dL (may transfuse if clinically indicated)
Hemoglobin (Hgb) >  g/dL (can be achieved with transfusion)
Hemoglobin (Hgb) >=  gm/dL (transfusion independent)
Hemoglobin (Hgb) >= . g/dL (no red blood cell [RBC] transfusion within past  days)\r\n* Hgb >= . g/dL for patients with anemia associated disease
Hemoglobin (Hgb) >=  g/dL (which may be post transfusion)
Hemoglobin (Hgb) >= . g/dL (transfusion before treatment is allowable if more than  days prior to study start)
Hemoglobin (Hgb) >= . g/dL ( g/L) without blood transfusion within  days
Hemoglobin (Hgb) >=  g/dL (use of transfusion to reach this threshold prior to study initiation is acceptable)
Hemoglobin (Hgb) >=  mg/dL (which may be post transfusion)
Hemoglobin (Hgb) >=  g/dL may be supported by transfusion and/or hematopoetic growth factors
Hemoglobin (Hgb) >= . g/dL (transfusion allowed), within  days of registration
Hemoglobin (Hgb) >= . g/dL (transfusion or erythropoietin-like substances not permitted prior to baseline evaluation)
Hemoglobin (Hgb) ? . g/dL within  days prior to randomization. Must not have required transfusion within  week of baseline Hgb assessment.
Hgb > . g/dl (without transfusion within  days)
Required prior to infusion of ATLCAR.CD cells: Hgb >= g/dL without transfusion support over preceding  days
Hemoglobin (Hgb) > . g/dL with no blood transfusion in the past  days
Hemoglobin (hgb) ? . g/dL (may be supported with transfusion)
Hemoglobin (Hgb) >=  g/dL ( g/L); <  g/dL (<  g/L) is acceptable if Hgb is corrected to >=  g/dL ( g/L) as by growth factor or transfusion prior to PET scan, obtained within  days prior to PET scan